Explore All Access
Check if your research matches the topics covered in Current Vascular Pharmacology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Current Vascular Pharmacology : Impact Factor & More
eISSN: 1875-6212pISSN: 1570-1611
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Current Vascular Pharmacology Key Metrics
CiteScore 
6.3
H-Index
67
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
0.8
Topics Covered on Current Vascular Pharmacology
Heart failure
Oxidative stress
Rebound effect
Type 2 Diabetes Mellitus
Clopidogrel
Metabolic syndrome
Matrix metalloproteinase
Blood pressure
Percutaneous coronary intervention
Anticoagulant
Vascular risk
Ezetimibe
Prime time
Insulin resistance
Aspirin
Diabetic nephropathy
Arterial stiffness
Ticagrelor
Hemodialysis
Nonalcoholic fatty liver disease
Current Vascular Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Vascular Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Vascular Pharmacology
Response to the Letter to the Editor: Rare Endocrine Disorders and Peripheral Arterial Disease.
- 4 Dec 2024
- Current vascular pharmacology
The Systemic Immune Inflammation Index as a Novel Predictive Biomarker for Contrast-Induced Acute Kidney Injury Risk Following Percutaneous Coronary Intervention: A Meta-Analysis of Cohort Studies.
- 5 Nov 2024
- Current vascular pharmacology
Assessment of Early Vascular Aging Ambulatory Score (EVAAs): A Large Population-based External Validation Study.
- 1 Nov 2024
- Current vascular pharmacology
Statins, Venous Thromboembolism and Cardiovascular Events.
- 1 Nov 2024
- Current vascular pharmacology
Statin Use May be Regarded as one of the General Measures for Reducing the Risk of Venous Thromboembolism.
- 1 Nov 2024
- Current vascular pharmacology
Neovascularization as a Leading Mechanism of Intraplaque Hemorrhage and Carotid Plaque Destabilization: A Narrative Review.
- 1 Nov 2024
- Current vascular pharmacology
Response to the Letter to the Editor: Rare Endocrine Disorders and Peripheral Arterial Disease.
- 4 Dec 2024
- Current vascular pharmacology
The Systemic Immune Inflammation Index as a Novel Predictive Biomarker for Contrast-Induced Acute Kidney Injury Risk Following Percutaneous Coronary Intervention: A Meta-Analysis of Cohort Studies.
- 5 Nov 2024
- Current vascular pharmacology
Assessment of Early Vascular Aging Ambulatory Score (EVAAs): A Large Population-based External Validation Study.
- 1 Nov 2024
- Current vascular pharmacology
Statins, Venous Thromboembolism and Cardiovascular Events.
- 1 Nov 2024
- Current vascular pharmacology
Statin Use May be Regarded as one of the General Measures for Reducing the Risk of Venous Thromboembolism.
- 1 Nov 2024
- Current vascular pharmacology
Neovascularization as a Leading Mechanism of Intraplaque Hemorrhage and Carotid Plaque Destabilization: A Narrative Review.
- 1 Nov 2024
- Current vascular pharmacology
Compare Similar Journals with Current Vascular Pharmacology
Select Journals to Compare with Current Vascular Pharmacology
Total journals - 10
You can select up to 3 Journals at a time
European Heart Journal
Publisher: OXFORD UNIV PRESS
Circulation
Publisher: LIPPINCOTT WILLIAMS & WILKINS
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of the American Heart Association
Publisher: WILEY
Journal of Clinical Medicine
Publisher: MDPI
Journal of the American College of Cardiology
Publisher: ELSEVIER SCIENCE INC
Scientific Reports
Publisher: NATURE PORTFOLIO
European Journal of Preventive Cardiology
Publisher: OXFORD UNIV PRESS
Medicine
Publisher: Elsevier
International Journal of Cardiology
Publisher: ELSEVIER IRELAND LTD
0 Journals Selected to compare with
Current Vascular Pharmacology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Current Vascular Pharmacology
How long has Current Vascular Pharmacology been actively publishing? 
Current Vascular Pharmacology has been in operation since 2003 till date.
What is the publishing frequency of Current Vascular Pharmacology?
Current Vascular Pharmacology published with a Bi-monthly frequency.
How many articles did Current Vascular Pharmacology publish last year?
In 2023, Current Vascular Pharmacology publsihed 48 articles.
What is the eISSN & pISSN for Current Vascular Pharmacology?
For Current Vascular Pharmacology, eISSN is 1875-6212 and pISSN is 1570-1611.
What is Citescore for Current Vascular Pharmacology?
Citescore for Current Vascular Pharmacology is 6.3.
What is the H Index for Current Vascular Pharmacology ?
H Index for Current Vascular Pharmacology is 67.
What is SNIP score for Current Vascular Pharmacology?
SNIP score for Current Vascular Pharmacology is 0.8.
What is the SJR for Current Vascular Pharmacology?
SJR for Current Vascular Pharmacology is Q1.
Who is the publisher of Current Vascular Pharmacology?
BENTHAM SCIENCE PUBL LTD is the publisher of Current Vascular Pharmacology.
